This is a $4,626,893.20 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Battelle Memorial Institute. The contract is for the evaluation of filovirus vaccines in general use prophylaxis (GUP) immunogenicity and filovirus challenge studies. Key subcontractors include Integrated Biotherapeutics, LLC, a small disadvantaged business, which provided services related to filovirus...
This contract was awarded by the Department of Health and Human Services National Institutes of Health to Alpha Genesis Inc., a for-profit S-corporation that provides nonhuman primates and bio research services. The $135,000.00 firm fixed-price delivery order is for per diem and testing costs associated with a nonhuman primate colony transferred from the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) to the National Institute of Allergy and Infectious Diseases...
This is a $3,044,549.00 fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The contract is for biomedical research and development work, with a period of performance ending on March 31, 2010. No set-aside designations were used. Resilience Government Services, a technology-focused biomanufacturing company, has...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Envigo Global Services Inc. (a subsidiary of Laboratory Corporation of America Holdings) for $5,305.60. The contract is for the provision of research models, specifically non-human primates such as cynomolgus, rhesus, and Chinese-origin macaques, along with associated services including...
This is a $15,433,226.00 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Battelle Memorial Institute, a nonprofit research organization, for preparedness testing of NIAID priority vaccines in general safety toxicology studies. The contract has a period of performance through December 31, 2025 and is a cost-plus-fixed-fee type. Battelle has subcontracted portions of the work to...
This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc. The $29,026,970.00 cost-plus-fixed-fee contract was awarded on September 9, 2019 to perform work under HHS-NIH-NIAID-BAA2018. The contract has an ultimate completion date of August 17, 2024 and does not have a set-aside designation....
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $8,046,548.00 cost-plus-fixed-fee delivery order contract to Alpha Genesis Inc., a for-profit Subchapter S Corporation, to provide specific pathogen free nonhuman primate breeding colonies in support of NIAID research programs. This contract is part of a larger indefinite delivery/indefinite quantity contract vehicle held by Alpha Genesis to enable...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $12,085,422.00 cost plus fixed fee delivery order contract to Sri International of West Menlo Park, California to perform animal model development and efficacy testing from September 19, 2022 through September 29, 2026. A subcontract valued at an undisclosed amount was also awarded to The Medical College of Wisconsin, Inc. to conduct a non-good laboratory...
This is a prime contract award to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services. The $14,898,362.53 cost-plus-fixed-fee contract is for biomedical research and development. It has a period of performance through December 31, 2011 and does not have a set-aside designation. Resilience Government Services is a technology-focused...
This is a federal contract award issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Battelle Memorial Institute for studies in non-human primate (NHP) models of filovirus infection. The contract, valued at $7,430,997.33, involves assay optimization and qualification for research on emerging infectious diseases. It is a cost-plus-fixed-fee contract with a period of performance through September 2026. The contract has no set-aside...
This is a $10,299,171.18 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Humanetics Corp, a for-profit biopharmaceutical company. The contract is for an NHP (non-human primate) efficacy study of BIO 300, a therapeutic candidate being developed by Humanetics to mitigate radiation-induced pneumonitis and pulmonary fibrosis. This work builds on Humanetics' prior federal grants from agencies like NIH, DoD, and the Army for research and development of radiation mitigation treatments and COVID-19 lung therapies. The contract has a period of performance through September 30, 2025 and does not utilize a set-aside. Humanetics also holds a separate $19.5 million Other Transaction Agreement from the Army to develop an oral formulation of BIO 300.